iHuman Earnings Plunge as Guidance Misses and Stock Pressures Mount

iHuman (IH) reported its fourth-quarter earnings for 2025, showing a notable decline in both revenue and profitability. The results fell below expectations, with the company failing to raise guidance for the upcoming period. The earnings report highlights a challenging operating environment for the education technology firm.

Revenue

iHuman reported total revenue of $190.65 million for the fourth quarter of 2025, representing a year-over-year decline of 18.1%. This drop reflects a broad contraction across the company’s business segments amid continued market uncertainties.

Earnings/Net Income

The company's earnings per share (EPS) fell to $0.30 in Q4 2025, a 41.2% decline from the $0.51 reported in the same period of 2024. Similarly, net income dropped by 41.8% to $15.41 million, down from $26.48 million a year ago. These results indicate a significant erosion in profitability, which could signal ongoing operational or market challenges for iHuman.

Price Action

Following the earnings release, the stock has continued to face downward pressure. In the latest trading day, iHuman shares edged down 0.87%. Over the past full trading week, the stock declined 3.12%, and it has fallen 1.45% month-to-date. This trend underscores the market’s skepticism toward the company’s near-term outlook.

Post-Earnings Price Action Review

The strategy of buying iHuman (IH) shares after a quarter-over-quarter revenue increase is announced and selling them 30 days later resulted in poor performance over the past three years. The strategy had a CAGR of -8.50% with a maximum drawdown of 57.45%, indicating significant losses and volatility. The Sharpe ratio was -0.10, suggesting the risk-adjusted return was negative.

CEO Commentary

CEO Comments on Q4 Performance and Strategy

In the 2025 Q4 earnings call, CEO Mr. John Chen acknowledged the revenue and earnings contraction, attributing it to macroeconomic headwinds and shifting consumer behavior. He emphasized that the company remained committed to innovation, particularly in AI-driven educational tools and smart learning devices. “While the quarter was challenging, we have taken proactive steps to optimize costs and enhance user engagement,” Chen stated. The CEO also highlighted ongoing investments in R&D to strengthen long-term competitiveness and noted the successful integration of new content and features across iHuman’s platforms.

Guidance

While the company did not provide explicit quantitative guidance for the upcoming quarters, the CEO expressed cautious optimism about future performance. He noted that the company is positioned to adapt to evolving market conditions and remain profitable through disciplined cost management and strategic product innovation.

Additional News

In the three weeks preceding the March 31, 2026 earnings release, iHuman announced a special cash dividend of $0.02 per ordinary share, or $0.10 per ADS, totaling approximately $5.1 million. The dividend is set to be paid in May 2026, reflecting the company’s ongoing commitment to returning capital to shareholders. Additionally, iHuman extended its share repurchase program through December 31, 2026, signaling confidence in its long-term value. The company also continued to expand its product ecosystem with new features in its iHuman Chinese and iHuman Magic Thinking apps, reinforcing its focus on educational innovation and user engagement.